TG THERAPEUTICS, INC. Quarterly Other Assets, Current in USD from Q4 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current assets classified as other.
Summary
Tg Therapeutics, Inc. quarterly Other Assets, Current history and growth rate from Q4 2010 to Q2 2024.
  • Tg Therapeutics, Inc. Other Assets, Current for the quarter ending June 30, 2024 was $7.05M, a 36.4% decline year-over-year.
Other Assets, Current, Quarterly (USD)
Other Assets, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $7.05M -$4.04M -36.4% Jun 30, 2024 10-Q 2024-08-09
Q1 2024 $8.1M +$3.64M +81.6% Mar 31, 2024 10-Q 2024-05-06
Q4 2023 $9.52M +$7.16M +304% Dec 31, 2023 10-Q 2024-08-09
Q3 2023 $12.1M +$9.13M +309% Sep 30, 2023 10-Q 2023-11-06
Q2 2023 $11.1M +$7.95M +254% Jun 30, 2023 10-Q 2023-08-04
Q1 2023 $4.46M +$438K +10.9% Mar 31, 2023 10-Q 2023-05-08
Q4 2022 $2.36M -$525K -18.2% Dec 31, 2022 10-K 2024-02-29
Q3 2022 $2.95M +$452K +18.1% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $3.14M +$186K +6.31% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $4.02M -$784K -16.3% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $2.88M +$1.8M +166% Dec 31, 2021 10-K 2023-03-01
Q3 2021 $2.5M +$1.86M +290% Sep 30, 2021 10-Q 2021-11-08
Q2 2021 $2.95M +$1.41M +92.1% Jun 30, 2021 10-Q 2021-08-06
Q1 2021 $4.8M +$2.86M +147% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 $1.08M +$472K +77.3% Dec 31, 2020 10-K 2022-03-01
Q3 2020 $641K -$223K -25.8% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 $1.54M +$549K +55.6% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $1.94M +$480K +32.8% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 $611K +$172K +39.2% Dec 31, 2019 10-K 2021-03-01
Q3 2019 $864K +$338K +64.3% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $987K +$171K +21% Jun 30, 2019 10-Q 2019-08-09
Q1 2019 $1.46M +$486K +49.7% Mar 31, 2019 10-Q 2019-05-10
Q4 2018 $439K +$2K +0.46% Dec 31, 2018 10-K 2020-03-02
Q3 2018 $526K -$270K -33.9% Sep 30, 2018 10-Q 2018-11-09
Q2 2018 $816K -$112K -12% Jun 30, 2018 10-Q 2018-08-09
Q1 2018 $978K -$79.7K -7.54% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 $437K +$221K +102% Dec 31, 2017 10-K 2019-03-01
Q3 2017 $796K +$296K +59.1% Sep 30, 2017 10-Q 2017-11-09
Q2 2017 $928K +$278K +42.8% Jun 30, 2017 10-Q 2017-08-09
Q1 2017 $1.06M +$327K +44.8% Mar 31, 2017 10-Q 2017-05-10
Q4 2016 $216K -$91.9K -29.8% Dec 31, 2016 10-K 2018-03-15
Q3 2016 $501K +$42.6K +9.31% Sep 30, 2016 10-Q 2016-11-09
Q2 2016 $650K +$101K +18.4% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 $731K +$28.7K +4.08% Mar 31, 2016 10-Q 2016-05-10
Q4 2015 $308K +$134K +77.2% Dec 31, 2015 10-K 2017-03-16
Q3 2015 $458K +$199K +77% Sep 30, 2015 10-Q 2015-11-09
Q2 2015 $549K +$351K +177% Jun 30, 2015 10-Q 2015-08-10
Q1 2015 $702K +$342K +95% Mar 31, 2015 10-Q 2015-05-11
Q4 2014 $174K +$126K +264% Dec 31, 2014 10-K 2016-03-15
Q3 2014 $259K +$140K +118% Sep 30, 2014 10-Q 2014-11-14
Q2 2014 $198K +$61.1K +44.7% Jun 30, 2014 10-Q 2014-07-24
Q1 2014 $360K +$134K +59.6% Mar 31, 2014 10-Q 2014-05-14
Q4 2013 $47.8K +$18.7K +64.1% Dec 31, 2013 10-K 2015-03-16
Q3 2013 $118K +$53.8K +83.2% Sep 30, 2013 10-Q 2013-11-14
Q2 2013 $137K +$47.2K +52.8% Jun 30, 2013 10-Q 2013-08-09
Q1 2013 $225K +$146K +185% Mar 31, 2013 10-Q 2013-05-14
Q4 2012 $29.1K -$58K -66.6% Dec 31, 2012 10-K 2014-03-07
Q3 2012 $64.7K -$36.1K -35.8% Sep 30, 2012 10-Q 2012-11-14
Q2 2012 $89.5K -$27.3K -23.4% Jun 30, 2012 10-Q/A 2012-09-07
Q1 2012 $79K Mar 31, 2012 10-Q 2012-05-14
Q4 2011 $87.2K -$54.4K -38.4% Dec 31, 2011 10-K 2013-03-21
Q3 2011 $101K Sep 30, 2011 10-Q 2011-11-14
Q2 2011 $117K Jun 30, 2011 10-Q/A 2011-09-14
Q4 2010 $142K Dec 31, 2010 10-Q 2011-11-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.